Pharma News

Pharma Courses 
PAGE Admission

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • India fast tracks emergency approvals for foreign produced COVID-19 vaccines
    14 April 2021

    India fast tracks emergency approvals for foreign produced COVID-19 vaccines

    Pharmacist India is following a comprehensive approach to tackle COVID-19 pandemic in a proactive and pre-emptive manner. In this context, as early as May 2020, India constituted a Task Force headed by Principal Scientific Advisor to encourage R&D for vaccine manufacture & constituted in August 2020 an Expert Group headed by Member, NITI to assist in roll out of the Covid vaccination programme. It was because of these strategies that India became the first country to have two “Made in India” Covid vaccines for domestic vaccination drive.

  • 14 April 2021
    Tika Utsav is pivotal because we know that there is no proven medicine to combat COVID-19

    Tika Utsav is pivotal because we know that there is no proven medicine to combat COVID-19. We need to maintain 6 feet social distancing, wear the mask, regular hand washing, and regular sanitization, maintain a good diet and fitness, mentioned Dr. Manoj Nesari, Adviser (Ay.) Ministry of AYUSH, Govt. of India in the webinar organized by PHD Chamber of Commerce and Industry on Importance of TikaUtsav-Covid Vaccination.

  • 13 April 2021
    Merck advances ATR inhibitor Berzosertib in small cell lung cancer

    Merck, a leading science and technology company announced key clinical advancements for berzosertib (M6620), an investigational, potent and selective ataxia telangiectasia and Rad3-related (ATR) inhibitor. Berzosertib is the leading asset in the company’s DNA damage response (DDR) inhibitor program and one of the most advanced ATR inhibitors in oncology clinical development industry-wide.

  • 13 April 2021
    Dr. Reddys Laboratories Gets Emergency Use Authorisation for Sputnik V in India

    Dr. Reddys Laboratories Ltd announced that it has received the permission from the Drug Controller General of India(DCGI)to import the Sputnik vaccine into India for restricted use in emergency situations as per the provisions of the New Drug and Clincial Trials rules, 2019 under the Drugs and Cosmetics Act.

  • 13 April 2021
    Sputnik V got DCGI nod

    Drug Controller General of India (DCGI) has approved the use of the Russian Sputnik V vaccine against coronavirus in the country. India has become the 60th country to approve Sputnik V. Sputnik V is one of only three coronavirus vaccines registered by India’s regulatory authorities.  Two vaccines - the Serum Institute of India's Covishield and Bharat Biotech's Covaxin - were cleared in January.

  • 12 April 2021
    India bans exports of injection Remdesivir and Remdesivir API

    India bans exports of injection Remdesivir and Remdesivir API and all domestic manufactures of Remdesivir to display on their website, details of their stockists/ distributors to facilitate access to the drug.

    India is witnessing a recent surge in COVID cases. As on 11.04.2021, there are 11.08 lakh active COVID cases and they are steadily increasing. This has led to a sudden spike in demand for Injection Remdesivir used in treatment of COVID patients. There is a potential of further increase in this demand in the coming days.

  • 9 April 2021
    NIH begins study of allergic reactions to Moderna, Pfizer-BioNTech COVID-19 vaccines

    A clinical trial is underway to determine whether people who are highly allergic or have a mast cell disorder are at increased risk for an immediate, systemic allergic reaction to the Moderna or Pfizer-BioNTech COVID-19 vaccines. A systemic allergic reaction to a vaccine occurs in one or more parts of the body beyond the injection site.

  • 8 April 2021
    Bioflavonoids Used in Citrobioshield Effectively Control Coronavirus in ICU and Wards

    The fresh surge in COVID-19 cases has now confirmed that the second wave of the coronavirus pandemic is here and is expanding its footprints in India. The study by the Centre for Cellular and Molecular Biology (CCMB) and CSIR-Institute of Microbial Technology (I M Tech) proved the presence of Coronavirus in air samples in Covid-19 wards of hospitals.

  • 8 April 2021
    AstraZeneca vaccine unlikely to cause blood clots, says MHRA

    Updated information is being provided for people and healthcare professionals on the possible risk of extremely rare and unlikely to occur specific types of blood clots following vaccination with the COVID-19 Vaccine AstraZeneca, the Medicines and Healthcare products Regulatory Agency (MHRA) said.

  • 7 April 2021
    Niramai receives CE mark approval enabling entry into EEA, Asia, Africa & Middle East

    Niramai, the deep-tech healthcare company offering an innovative AI-based, radiation-free breast cancer screening test has now received the CE mark approval, ISO 13485 and MDSAP (Medical Device Single Audit Programme) international certifications. The CE mark approval indicates that the product may be sold freely in any part of the European Economic Area (EEA) as well as applicable to many Asian, African and Middle East countries.

Subscribe to Pharma News